ERS Advocacy Council

Advocacy is a core pillar of ERS. The Society’s involvement in advocacy is co-ordinated via the ERS Advocacy Council.

About

Article I of the ERS Constitution outlines a key objective of ERS: to promote respiratory health in order to alleviate suffering from respiratory disease. The Advocacy Council plays an important role in this objective. The Council is constituted via the by-laws of ERS and is comprised of key leaders within the Society.

Objectives
  • Increase resources to manage patient and respiratory health problems; to research respiratory-related disorders; and to promote education for healthcare professionals in respiratory health.
  • Coordinate all matters pertaining to advocacy of the Tobacco Control Committee and the Environment and Health Committee.
  • Link with other organisations to promote awareness for respiratory disorders at national, EU and global level.

Council members

Arzu Yorgancioğlu - profile image
Arzu Yorgancioğlu
Advocacy Council Chair

Declaration of Interests

Declaration of Interests of Ayşe Arzu Yorgancıoğlu

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work
CompanyAreaProductAmount of funds received*
Astra zenecaAdvisory Boardfuture plansA
GSKAdvisory Boardfuture plansA
Novartis Advisory BoardplansA
SandozInvited speakerpresentationA
ChiesiInvited speaker&Ad.BoardpresentationA
DEVAInvited speaker&Ad.BoardpresentationA
Abdi İbrahimInvited speaker&Ad.BoardpresentationA
Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
MSDClinical ResearchB
SanofiClinical ResearchB

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Anita Simonds - profile image
Anita Simonds
President

Declaration of Interests

Declaration of Interests of Anita Simonds

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
ACI ClinicalMember of Endpoint review panel for bioALS trialB

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Marc Humbert - profile image
Marc Humbert
President Elect

Declaration of Interests

Declaration of Interests of Marc Humbert

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work
CompanyAreaProductAmount of funds received*
AcceleronPulmonary HypertensionSotaterceptC
MerckPulmonary HypertensionRiociguatC
Johnson & JohnsonPulmonary HypertensionMacitentan, selexipagC
BayerPulmonary HypertensionRiociguatB
FerrerPulmonary HypertensionTreprostinilB
GSKAsthmaMepolizumabB
AstraZenecaAsthmaBenralizumabB
SanofiAsthmaDupilumabB
NovartisAsthmaOmalizumabC
Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
Johnson & JohnsonTranslational research grant to the research laboratoryD
BayerTranslational research grant to the research laboratoryC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Carlos Robalo Cordeiro - profile image
Carlos Robalo Cordeiro
Vice President

Declaration of Interests

Declaration of Interests of Carlos Robalo Cordeiro

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Kjeld Hansen - profile image
Kjeld Hansen
European Lung Foundation Chair

Declaration of Interests

Declaration of Interests of Kjeld Hansen

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Jonathan Grigg - profile image
Jonathan Grigg
Chair of the ERS Tobacco Control Committee

Zorana J. Andersen - profile image
Zorana J. Andersen
Chair of the ERS Environment and Health Committee

Craig Wheelock - profile image
Craig Wheelock
Director of Scientific Relations with the EU

Ivan Solovic - profile image
Ivan Solovic
Advocacy Council expert on TB

Guy Joos - profile image
Guy Joos
Advocacy Council expert on NCDs

Tobias Welte - profile image
Tobias Welte
Representative of the Biomed Alliance

Declaration of Interests

Declaration of Interests of Tobias Welte

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
CompanyPurpose of PaymentAmount of funds received*
AstraZenecafees for lectures/advisory boardC
GSKfees for lectures/advisory boardC
Boehringerfees for lectures/advisory boardB
Berlin Chemiefees for lecturesB
Novartisfees for lectures/advisory boardC
MSDfees for lectures/advisory boardB
Grifolsfees for lectures/advisory boardB
Bayerfees for lecturesB
Rochefees for lectures/advisory boardB
Sanofi Aventisfees for lectures/advisory boardC
Shionogifees for lectures/advisory boardB
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Joanna Chorostowska-Wynimko - profile image
Joanna Chorostowska-Wynimko
Secretary General

Declaration of Interests

Declaration of Interests of Joanna Chorostowska-Wynimko

Annual Declaration of Interest 2020-2021

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
CompanyPurpose of PaymentAmount of funds received*
Grifolsadvisory boardB
CSL Behringadvisory board, lecturesB
MSDadvisory board, lecturesB
BMSadvisory board, lecturesB
Pfizeradvisory board, lecturesB
Amgenadvisory board, lecturesB
Takedaadvisory board, lecturesB
Lekamadvisory board, lecturesB
Astra Zenecaadvisory board, lecturesB
RochelecturesA
Novartisadvisory board, lecturesB
Boehringer-IngelheimlecturesB
Personal Travel Grants or expenses for conferences etc.
CompanyPurpose and Nature of BenefitAmount of funds received*
Astra ZenecaconferenceA
MSDconferenceA
AmgenconferenceA
PfizerconferenceA
Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
Pfizerinvestigator initiated grantC
Astra Zenecainvestigator initiated grantD
CSL Behringinvestigator initiated grantC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000

Learn about ERS’s advocacy activities and policy areas

Read more